On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: Does the therapy-dose matter?

Brain and Cognition

Volumn 71, Issue 2, 2009, Pages 84-91

  Torta, Diana Maria Elena ^a   Castelli, Lorys ^a   Zibetti, Maurizio ^a   Lopiano, Leonardo ^a   Geminiani, Giuliano ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Decision making; Dopaminergic therapy; Impulsivity; Parkinson's disease; Reward; Working memory

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; TOLCAPONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DECISION MAKING; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; IMPULSIVENESS; MALE; MEMORY DISORDER; MENTAL CAPACITY; MENTAL PERFORMANCE; MENTAL TASK; PARKINSON DISEASE; PRIORITY JOURNAL; WORKING MEMORY;

AGED; ANALYSIS OF VARIANCE; CHOICE BEHAVIOR; DECISION MAKING; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REGRESSION ANALYSIS; REWARD;

EID: 68749115058     PISSN: 02782626     EISSN: 10902147     Source Type: Journal    
DOI: 10.1016/j.bandc.2009.04.003     Document Type: Article

References (45)

1. Agid Y., Ruberg M., Hirsch E., Raisman-Vozari R., Vyas S., Faucheux B., et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Advances in Neurology 60 (1993) 148-164
2. Bazanis E., Rogers R., Dowson J., Taylor P., Meux C., Staley C., et al. Neurocognitive deficits in decision-making and planning of patients with DSM-III-R borderline personality disorder. Psychological Medicine 32 (2002) 1395-1405
3. Beato R., Levy R., Pillon B., Vidal C., Tezenas du Montcel S., Deweer B., et al. Working memory in Parkinson's disease patients. Arquivos de Neuro-psiquiatria 66 2-A (2008) 147-151
4. Bechara A., Damasio H., Damasio A.R., and Anderson S.W. Emotion, decision making and the prefrontal cortex. Cerebral Cortex 10 (2000) 295-307
5. Castelli L., Perozzo P., Zibetti M., Crivelli B., Morabito U., Lanotte M., et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: Effects on cognition, mood, anxiety and personality traits. European Neurology 55 3 (2006) 136-144
6. Clark L., Bechara A., Damasio H., Aitken M., Sahakian B., and Robbins T. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 131 (2008) 1311-1322
7. Cools R., Barker R.A., Sahakian B.J., and Robbins T. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex 11 (2001) 1136-1143
8. Cools R., Barker R.A., Sahakian B.J., and Robbins T. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 4 (2003) 1431-1441
9. Cools R., Clark L., Owen A.M., and Robbins T.W. Defining the neural mechanism of probabilistic reversal learning using event-related functional magnetic resonance. The Journal of Neuroscience 22 (2002) 4563-4567
10. Cooper J., Sagar H., Doherty S., Jordan N., Tidswell P., and Sullivan E. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain 115 (1992) 1701-1725
11. Costa A., Peppe A., Dell'Agnello G., Carlesimo G., Murri L., Bonuccelli U., et al. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dementia and Geriatric Cognitive Disorders 15 2 (2003) 55-66
12. Czernecki V., Pillon B., Houeto J.L., Pochon J.B., Levy R., and Dubois B. Motivation, reward, and Parkinson's disease: Influence of dopatherapy. Neuropsychologia 40 (2002) 2257-2267
13. Defer G., Widner H., Marié R., Rémy P., and Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders 14 4 (1999) 572-584
14. Dreher J.-C., Guigon E., and Burnod Y. A model of prefrontal cortex dopaminergic modulation during the delayed alternation task. Journal of Cognitive Neuroscience 14 6 (2002) 853-865
15. First M. Structured clinical interview for DSM-IV axis disorders, patients edition (SCID), version 2 (1995), New York State Psychiatric Institute, Biometrics Research, New York
16. Folstein M.F., Folstein S.E., and McHugh P.R. Mini mental state: A practical method for grading the cognitive status of patients for the clinician. Journal of Psychiatric Research 12 (1975) 189-198
17. Goerendt I.K., Lawrence A.D., and Brooks D.J. Reward processing in health and Parkinson's disease: Neural organisation and reorganization. Cerebral Cortex 14 (2004) 73-80
18. Gotham A., Brown R., and Marsden C. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 111 (1988) 299-321
19. Grosset K., Needleman F., Macphee G., and Grosset D. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five-drug dose conversion table. Movement Disorders 19 (2004) 1370-1374
20. Hollerman J., and Schultz W. Dopamine neurons report an error in the temporal prediction of reward during learning. Nature Neuroscience 1 (1998) 304-309
21. Howell D. Statistical methods for psychology (1997), Wadsworth, Belmont
22. Kish S.J., Shannak K., and Hornykiewicz O. Uneven patterns of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. New England Journal of Medicine 318 (1988) 876-880
23. Kulisevsky J. Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs & Aging 16 5 (2000) 365-379
24. Kulisevsky J., Avila A., Barbanoj M., Antonijoan R., Berthier M., and Gironell A. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain 119 6 (1996) 2121-2132
25. Kulisevsky J., Pascual-Sedano B., Barbanoj M., Gironell A., Pagonabarraga J., and García-Sánchez C. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study. Movement Disorders 22 1 (2007) 62-67
26. Lang A.E., and Widner H. Deep brain stimulation for Parkinson's disease: Patient selection and evaluation. Movement Disorders 17 (2002) s94-s101
27. Lange K., Robbins T., Marsden C., James M., Owen A., and Paul G. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107 2-3 (1992) 394-404
28. Lanotte M., Rizzone M., Bergamasco B., Faccani G., Melcarne A., and Lopiano L. Deep brain stimulation of the subthalamic nucleus: Anatomical, neurophysiological, and outcome correlations with the effects of stimulation. Journal of Neurology Neurosurgery and Psychiatry 72 1 (2002) 53-58
29. Lawrence A.D., Evans H., and Lees J. Compulsive use of dopamine replacement therapy in Parkinson's disease: Reward systems gone awry?. Lancet Neurology 2 (2003) 595-604
30. Lewis S., Slabosz A., Robbins T., Barker R., and Owen A. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 43 6 (2005) 823-832
31. Lopiano L., Rizzone M., Bergamasco B., Tavella A., Torre E., Perozzo P., et al. Deep brain stimulation of the subthalamic nucleus in PD: An analysis of the exclusion causes. Journal of the Neurological Sciences 195 2 (2002) 167-170
32. Manes F., Sahakian B., Clark L., Rogers R., Antoun N., Aitken M., et al. Decision making process following damage to the prefrontal cortex. Brain 125 (2002) 624-639
33. Marini P., Ramat S., Ginestroni A., and Paganini M. Deficit of short-term memory in newly diagnosed untreated Parkinsonian patients: Reversal after L-dopa therapy. Neurological Sciences 23 4 (2003) 184-185
34. Mavaddat N., Kirkpatrick P., Rogers R., and Sahakian B. Deficits in decision-making in patients with aneurysms of the anterior communicating artery. Brain 123 (2000) 2109-2117
35. Moustafa A.A., Sherman S.J., and Frank M.J. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism. Neuropsychologia 46 (2008) 3144-3156
36. O'Leary K., Brouwers P., Gardner D., and Cowdry R. Neuropsychological testing of patients with borderline personality disorder. The American Journal of Psychiatry 148 (1991) 106-111
37. Owen A., Sahakian B., Semple J., Polkey C., and Robbins T. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalohippocampectomy in man. Neuropsychologia 33 1 (1995) 1-24
38. Pagonabarraga J., Garcia-Sanchez C., Llebaria G., Pascual-Sedano B., Gironell A., and Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Movement Disorders 22 10 (2007) 1430-1435
39. Pochon J.B., Levy R., Fossati P., Lehericy S., Poline J.B., Pillon B., et al. The neural system that bridges reward and cognition in humans: A fMRI study. Proceedings of the National Academy of Sciences 99 8 (2002) 5669-5674
40. Poewe W., Berger W., Benke T., and Schelosky L. High-speed memory scanning in Parkinson's disease: Adverse effects of levodopa. Annals of Neurology 29 6 (1991) 670-673
41. Robbins T. Chemistry of the mind: Neurochemical modulation of the prefrontal cortex. The Journal of Comparative Neurology 493 (2005) 140-146
42. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers; evidence for monoaminergic mechanism. Neuropsychopharmacology 20 (1999) 322-339
43. Sohn M., Ursu S., Anderson J.R., Stenger V.A., and Carter C.S. The role of prefrontal cortex in task switching. Proceedings of the National Academy of Sciences 97 (2000) 13448-13453
44. Swainson R., Rogers R., Sahakian B., Summers B., Polkey C., and Robbins T. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: Possible adverse effects of dopaminergic medication. Neuropsychologia 38 5 (2000) 596-612
45. Torta D.M.E., and Castelli L. Reward pathways in Parkinson's disease: Clinical and theoretical implications. Psychiatry and Clinical Neurosciences 62 (2008) 204-214